Whole-exome sequencing identifies a de novo mutation in TRPM 4 involved in pleiotropic ventricular septal defect

Zhen Jia,Fengbiao Mao,Lu Wang,Mingzhen Li,Yueyi Shi,Baorong Zhang,Guolan Gao
2017-01-01
Abstract:Background: As a structural defect due to abnormal heart formation, congenital heart disease (CHD) is the most common birth defect. Most of the known causes of congenital heart disease are sporadic genetic changes in results of either focal mutations or deletion. The purpose of this study was to investigate de novo mutation of CHD. Methods: Whole exome sequencing analysis was performed on DNA of venous blood of his parents and leg muscles from the child with CHD to scan for de novo mutations. Sanger sequencing was performed to verify these candidate mutations in the CHD tissue, parental blood, Clinical and fetal echocardiography examinations were performed on the patient diagnosed with CHD. Results: The sequencing methods found a de novo missense mutation c.A25G (p.S9G) in exon 2 of gene TRPM4, which plays a critical role in mediating transport of monovalent cations across membranes. The de novo missense mutation led to the conversion of serine acid to glycine acid (p.S9G), resulting in a deleterious mutation in the TRPM4 protein. Multiple-sequence alignments showed that codon 9, where the mutation (c.A25G) occurred, was located within a phylogenetically conserved region. Conclusions: We report a de novo missense mutation c.A25G (p.S9G) in TRPM4 for Chinese patient with CHD. Our findings broaden the genotypic spectrum of CHD and provide new molecular insight into future clinical genetic diagnosis of CHD.
What problem does this paper attempt to address?